Synthetic Artificial Blood Vessels Market to Grow at 8.2% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global synthetic artificial blood vessels market was valued at USD 2.8 billion in 2024 and is projected to reach USD 5.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11544/synthetic-artificial-blood-vessels-market Synthetic artificial blood vessels, clinically referred to as vascular grafts, are essential medical prostheses engineered to bypass or replace damaged, diseased, or occluded natural blood vessels. These critical conduits are predominantly constructed from advanced biomaterials such as Expanded Polytetrafluoroethylene (ePTFE), Polyethylene Terephthalate (PET), and Polyurethane. Their primary function is to maintain or restore blood flow in patients suffering from severe cardiovascular conditions, including peripheral artery disease, aortic aneurysms, and vascular access for hemodialysis. The established utility and continual innovation in graft materials underpin their indispensable role in vascular surgery and interventional cardiology.